VERU
USDVeru Inc. Common Stock
$0.653-0.007 (-1.061%)
Precio en Tiempo Real
Healthcare
Biotecnología
Estados Unidos
Gráfico de Precios
Loading Chart...
Métricas Clave
Métricas de Mercado
Apertura
$0.660
Máximo
$0.685
Mínimo
$0.612
Volumen
1.69M
Fundamentos de la Empresa
Capitalización de Mercado
95.7M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
2.33M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Mínimo $0.45Actual $0.653Máximo $1.42
Noticias Relacionadas
GlobeNewswire
Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone
--Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial efficacy and
Ver más
GlobeNewswire
Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress
--Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second quarter of
Ver más
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.